Navigation Links
Smoking Worsens Prognosis for IPF Patients
Date:1/21/2008

Study tackles anomaly that current puffers live longer with untreatable lung disease

MONDAY, Jan. 21 (HealthDay News) -- Current and former smokers with the lung disease idiopathic pulmonary fibrosis (IPF) have a worse prognosis than nonsmokers, says a British study.

IPF is untreatable, and patients usually die within five years of diagnosis. Previous research had suggested that current smokers with IPF may live longer than former smokers, but the authors of this new study said that was likely due to a "healthy smoker effect."

"Smoking is associated with a higher degree of mortality in IPF, and an earlier finding, suggesting the contrary, was almost certainly due to the fact that smokers tend to stop smoking when disease becomes more severe -- and so current smoking is linked to milder disease," research leader Dr. Athol U. Wells, of the Interstitial Lung Disease Unit at the Royal Brompton Hospital in London, said in a prepared statement.

Publishing in the second issue for January of the American Journal of Respiratory and Critical Care Medicine, Wells and his colleagues analyzed the medical records of 249 IPF patients and found nonsmokers survived longer than current or former smokers.

"We speculate as to whether this reflects disease co-morbidity -- that is, excess mortality from non-pulmonary disease ascribable to smoking -- or an effect of smoking in driving progression of lung disease," Wells said.

The team is doing further research in this area.

"The next step is to pursue the idea that mechanisms linked to smoking cause progression of pulmonary fibrosis. If we can then understand these mechanisms better, this may give us new treatment options," Wells said.

More information

The U.S. National Heart, Lung, and Blood Institute has more about idiopathic pulmonary fibrosis.



-- Robert Preidt



SOURCE: American Thoracic Society, news release, Jan. 15, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Lighting up the powerful global smoking lobby
2. Smoking belies milder disease but worse prognosis for IPF patients
3. Prominent Respiratory Therapist and Author Joins StopSmokingConnection.com as a COPD Expert
4. Smoking in Movies Linked to Kids Lighting Up
5. Hookah Smoking as Tough on Lungs as Cigarettes
6. Smoking rate among New York City teens was lowest on record in 2007
7. Parents Smoking Boosts Childs Allergy Risk
8. Heart attack risk from smoking due to genetics
9. Domestic violence identified as stressor associated with smoking
10. New Report: Tobacco Regulation Would Save Iowa $449 Million in Health Care Costs by Preventing 25,700 Kids from Smoking
11. Statement by the American Legacy Foundation(R) on Youth Smoking Rates
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Smoking Worsens Prognosis for IPF Patients
(Date:12/7/2016)... TX (PRWEB) , ... December 07, 2016 , ... ... 2016 Top 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. Live ... recognize the year’s best in pioneering, inventive, and ultimately successful projects undertaken by ...
(Date:12/7/2016)... Scottsdale, AZ (PRWEB) , ... ... ... pioneer, ElectroMedical Technologies, announced its newest portable bioelectronic medicine device WellnessPro Plus ... , WellnessPro Plus substantially enhances the WellnessPro platform by expanding the treatment ...
(Date:12/7/2016)... ... 2016 , ... “Walking With God: Inspirational Lessons from My Life's Journey”: ... be aware of God's direction in their lives. “Walking With God: Inspirational Lessons from ... active church leader. , Sanford says, “I enjoy sharing the true stories ...
(Date:12/7/2016)... ... December 07, 2016 , ... Dr. Greg Leyer, the ... Probiotic Association’s Washington DC workshop on November 2nd. The conference was an opportunity ... probiotic dietary supplement regulations. , Dr. Leyer spoke about two main topics ...
(Date:12/6/2016)... ... 2016 , ... The International Vaccine Institute (IVI) and GeneOne ... Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The collaboration will accelerate MERS-CoV vaccine development ... in the event of a future outbreak. , IVI and GeneOne held a ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... --  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... the ralinepag phase 2 trial.  Ralinepag is an oral, ... the treatment of pulmonary arterial hypertension (PAH). The study ... "This marks an important step in the development of ... our pipeline," said Amit Munshi , Arena,s President ...
(Date:12/7/2016)... , Dec. 7, 2016   TraceLink Inc ... for connecting the Life Sciences supply chain and ... today announced that Tjoapack has selected TraceLink,s serialization ... customers comply with the rapidly approaching serialization deadlines ... (DSCSA) in 2017 and the EU Falsified Medicines ...
(Date:12/7/2016)... ZIONA SCIENCE PARK , ... biotechnology company Kadimastem (TASE: KDST) announced today the signing of a ... collaboration between the companies. The synergy between the companies will assist ... collaboration as a worldwide leader in innovative treatment for severe diseases ... ...
Breaking Medicine Technology: